MedPath
HSA Approval

TERASIN TABLET 2 mg

SIN11600P

TERASIN TABLET 2 mg

TERASIN TABLET 2 mg

July 31, 2001

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMD PHARMACEUTICALS PTE. LTD.
Licence HolderMD PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

G04CA03

terazosin

Manufacturer Information

MD PHARMACEUTICALS PTE. LTD.

DAEWON PHARM CO LTD

Active Ingredients

TERAZOSIN HCl EQV TERAZOSIN

2 mg

Terazosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.